Pharmacological modulation of sigma 2 receptor shows in vivo neuroprotective effect after TBI May 2, 2019
U.K. MHRA approves CTA for first-in-human study of DYN-101 for centronuclear myopathies April 30, 2019
GIRK activator VU-0466551 shows analgesic effects alone or combined with morphine in pain models April 30, 2019
RSS